Actively Recruiting
Feasibility and Efficacy of Cognitive-Behavioral Therapy for Patients With ADHD/Behavioral Addiction Comorbidity
Led by University Hospital, Tours · Updated on 2025-06-25
54
Participants Needed
3
Research Sites
72 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Tours
Lead Sponsor
N
Nantes University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The main objective of this pilot study is to assess preliminary data on the feasibility of CBT and its evaluation in a randomised trial in patients with co-occurring ADHD and behavioural addiction: Evaluation and comparison of the 12-week retention rate of patients randomised to CBT compared with patients in the 'treatment as usual' control arm. In order to meet the objective, the patient will take part in a standardized assessment, followed by a therapeutic intervention and a new standardized assessment after the intervention. The standardized assessment consists as follows : * firstly, 7 self-questionnaires to be completed by the patient, lasting around 45 min, aimed at assessing his or her socio-demographic data; current symptoms, quality of life and functional impact related to ADHD; impulsivity, emotion regulation and assessment of possible anxiety-depressive disorders. * Then the patient will follow the 10 session of cognitivo behavioural psychotherapy. * At 12-weeks post-inclusion, an assessment visit is carried out during which a battery of tests will be administered. This is followed by a research interview with a professional, aimed at gathering his or her experiences.
CONDITIONS
Official Title
Feasibility and Efficacy of Cognitive-Behavioral Therapy for Patients With ADHD/Behavioral Addiction Comorbidity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient over 18 (age 65 18 years)
- Patient treated in an outpatient addictology department at the CHU of Brest, Nantes or Tours and presenting an ADHD/behavioral addiction comorbidity
- Patient affiliated to a social security scheme
- For patients treated with methylphenidate: no change in treatment dosage during the previous three months
- For patients not treated with methylphenidate: no introduction of methylphenidate within the next three months
You will not qualify if you...
- Patients with psychotic disorders (assessed by clinician)
- Pregnant or breast-feeding women
- Patients under protective supervision (guardianship or curatorship)
- Persons under court protection
- Persons deprived of their liberty
- Patients who do not meet the eligibility criteria for CBT (e.g., cognitive impairment, hearing impairment)
- Physical inability to participate in CBT sessions (e.g., lack of telephone, foreseeable unavailability)
- Difficulty understanding self-questionnaires, including illiteracy
- Participation in another interventional research protocol involving another psychotherapeutic or pharmacological intervention that may have an impact on clinical outcome
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
CHU La Cavale Blanche
Brest, France
Not Yet Recruiting
2
Centre Hospitalier Saint Jacques
Nantes, France
Active, Not Recruiting
3
CHRU De Tours
Tours, France
Actively Recruiting
Research Team
S
Servane BARRAULT, Dr
CONTACT
A
Amélie Delage
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here